Fig. 3From: The trajectory of a range of commonly captured symptoms with standard care in people with kidney failure receiving haemodialysis: consideration for clinical trial designChange in symptoms prevalence over 18 months in people with moderately affected or worse at baseline. This figure was stratified by (A) symptoms with ≦20% change and (B) > 20% change in the prevalence in those reporting severe degree. Additional files 7 and 8 support this figureBack to article page